DrugPatentWatch Database Preview
PHENTERMINE HYDROCHLORIDE Drug Profile
When do Phentermine Hydrochloride patents expire, and when can generic versions of Phentermine Hydrochloride launch?
Phentermine Hydrochloride is a drug marketed by Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Kvk Tech, Lannett, Lannett Co Inc, Nuvo Pharm, Sandoz, Sun Pharm Industries, Teva, Tg United Inc, Upsher Smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms Usa Inc, Actavis Elizabeth, Kvk Tech Inc, Novast Labs, Polygen Pharms, Prinston Inc, Sandoz Inc, and Sun Pharm Inds Inc. and is included in eighty-seven NDAs.
The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
Summary for PHENTERMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 31 |
| NDAs: | 87 |
| Suppliers / Packagers: | 44 |
| Bulk Api Vendors: | 33 |
| Clinical Trials: | 27 |
| Patent Applications: | 717 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PHENTERMINE HYDROCHLORIDE |
| DailyMed Link: | PHENTERMINE HYDROCHLORIDE at DailyMed |
Pharmacology for PHENTERMINE HYDROCHLORIDE
| Drug Class | Sympathomimetic Amine Anorectic |
| Physiological Effect | Appetite Suppression Increased Sympathetic Activity |
Synonyms for PHENTERMINE HYDROCHLORIDE
| .alpha.-Methylamphetamine hydrochloride |
| .alpha.,.alpha.-Dimethylphenethylamine hydrochloride |
| (1,1-DIMETHYL-2-PHENYL)ETHYLAMINE HYDROCHLORIDE |
| 0K2I505OTV |
| 1-Phenyl-2-methyl-2-aminopropane hydrochloride |
| 1-phenyl-2-methyl-2-aminopropanehydrochloride |
| 1-Phenyl-2-methyl-2-propylamine Hydrochloride |
| 1,1-Dimethyl-2-phenylethylamine hydrochloride |
| 1197-21-3 |
| 122-09-8 (Parent) |
| 2-Amino-2-methyl-1-phenylpropane hydrochloride |
| 2-methyl-1-phenyl-2-propanamine hydrochloride |
| 2-Methyl-1-phenylpropan-2-amine hydrochloride |
| 2-methyl-1-phenylpropan-2-amine;hydrochloride |
| AC1L2F9M |
| Adipex-p (TN) |
| AK-81487 |
| AKOS015891196 |
| alpha-Methylamphetamine hydrochloride |
| alpha-methylamphetaminehydrochloride |
| alpha,alpha-dimethyl-phenethylaminhydrochloride |
| alpha,alpha-Dimethylphenethylamine hydrochloride |
| ANW-58508 |
| AOB5784 |
| API0007710 |
| AS01627 |
| BENZENEETHANAMINE, A,A-DIMETHYL-, HYDROCHLORIDE (1:1) |
| Benzeneethanamine, alpha,alpha-dimethyl-, hydrochloride |
| Benzeneethanamine, alpha,alpha-dimethyl, hydrochloride |
| Benzeneethanamine,.alpha.-dimethyl, hydrochloride |
| benzeneethanamine,alpha,alpha-dimethyl,hydrochloride |
| CCG-221139 |
| CHEBI:50506 |
| CHEMBL1200912 |
| CTK6A7128 |
| D05459 |
| DEA No. 1640 |
| DTXSID20152550 |
| Duromine Hydrochloride |
| EINECS 214-821-9 |
| Fastin |
| Fastin (TN) |
| FT-0673716 |
| I01-8880 |
| I14-44888 |
| Inoamin Hydrochloride |
| Ionamin Hydrochloride |
| Linyl Hydrochloride |
| Lipopill Hydrochloride |
| Lomaira |
| Lonamin Hydrochloride |
| LS-103359 |
| MG 18370 |
| MG 18570 |
| Mirapront Hydrochloride |
| MLS003882563 |
| NCAIGTHBQTXTLR-UHFFFAOYSA-N |
| Normephentermine Hydrochloride |
| NSC 44090 |
| NSC-44090 |
| NSC44090 |
| Obestin-30 |
| Oby-Trim |
| Omnibex Hydrochloride |
| Ona-Mast |
| Ona-Mast hydrochloride |
| Phenethylamine, alpha,alpha-dimethyl-, hydrochloride |
| Phenteral |
| Phenteramine hydrochloride |
| Phentermine HCl |
| Phentermine hydrochloride (USP) |
| Phentermine hydrochloride [USAN] |
| Phentermine hydrochloride [USP] |
| Phentermine hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Phentermyl Wyncaps |
| Phenyl-t-butylamine hydrochloride |
| phenyl-t-butylaminehydrochloride |
| Phenyl-tert-butylamine Hydrochloride |
| S 58 |
| SCHEMBL41585 |
| SMR000058739 |
| Suprenza |
| TC-147253 |
| TL8000587 |
| Tora |
| UNII-0K2I505OTV |
| Wilpo (VAN) |
| Wilpo Hydrochloride |
| wilpohydrochloride |
| WLN: ZX1&1&1R &GH |
US Patents and Regulatory Information for PHENTERMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 083923-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Nuvo Pharm | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 205019-001 | Dec 5, 2014 | AA | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Ivax Pharms | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 086329-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Prinston Inc | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | TABLET;ORAL | 040377-001 | Jan 4, 2002 | AA | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Sandoz | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 088414-001 | Oct 19, 1983 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
